BREELET 2,5 MG COM REV CT BL AL PLAS PVDC/PVC TRANS X 30
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1064602190012 -
GGREM
519522020030404 -
Código de barras
7898943602671
O que a fonte publica
- Detentor do registro
- LABORATORIO QUIMICO FARMACEUTICO BERGAMO LTDA
- Princípios ativos
- LETROZOL
- Embalagem
- 2,5 MG COM REV CT BL AL PLAS PVDC/PVC TRANS X 30
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Similar
- Classe terapêutica
- L2B3 - CITOSTÁTICOS INIBIDORES DA AROMATASE
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "BREELET 2,5 MG COM REV CT BL AL PLAS PVDC/PVC TRANS X 30",
"holder": "LABORATORIO QUIMICO FARMACEUTICO BERGAMO LTDA",
"stripe": "Tarja Vermelha",
"barcodes": [
"7898943602671"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "519522020030404",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": true,
"holderTaxId": "61.282.661/0001-41",
"priceRegime": "Regulado",
"productName": "BREELET",
"productType": "Similar",
"hospitalOnly": false,
"presentation": "2,5 MG COM REV CT BL AL PLAS PVDC/PVC TRANS X 30",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "930.54",
"icms-12": "1057.43",
"icms-17": "1121.13",
"icms-18": "1134.80",
"icms-19": "1148.81",
"icms-20": "1163.18",
"icms-21": "1177.90",
"icms-22": "1193.00",
"icms-23": "1208.49",
"icms-17.5": "1127.93",
"icms-19.5": "1155.95",
"icms-20.5": "1170.49",
"icms-22.5": "1200.70",
"icms-12-alc": "1044.74",
"icms-17-alc": "1107.68",
"icms-18-alc": "1121.19",
"icms-19-alc": "1135.03",
"icms-20-alc": "1149.22",
"icms-21-alc": "1163.76",
"icms-22-alc": "1178.68",
"icms-23-alc": "1193.99",
"withoutTaxes": "919.37",
"icms-17.5-alc": "1114.39",
"icms-19.5-alc": "1142.08",
"icms-20.5-alc": "1156.44",
"icms-22.5-alc": "1186.29"
},
"pisCofinsList": "Positiva",
"substanceText": "LETROZOL",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "1282.65",
"icms-12": "1457.56",
"icms-17": "1545.36",
"icms-18": "1564.20",
"icms-19": "1583.51",
"icms-20": "1603.32",
"icms-21": "1623.61",
"icms-22": "1644.43",
"icms-23": "1665.78",
"icms-17.5": "1554.73",
"icms-19.5": "1593.36",
"icms-20.5": "1613.40",
"icms-22.5": "1655.04",
"icms-12-alc": "1444.29",
"icms-17-alc": "1531.30",
"icms-18-alc": "1549.98",
"icms-19-alc": "1569.11",
"icms-20-alc": "1588.73",
"icms-21-alc": "1608.83",
"icms-22-alc": "1629.46",
"icms-23-alc": "1650.62",
"withoutTaxes": "1270.98",
"icms-17.5-alc": "1540.58",
"icms-19.5-alc": "1578.86",
"icms-20.5-alc": "1598.71",
"icms-22.5-alc": "1639.98"
},
"invalidBarcodes": [],
"activeSubstances": [
"LETROZOL"
],
"therapeuticClass": "L2B3 - CITOSTÁTICOS INIBIDORES DA AROMATASE",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1064602190012",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "L2B3",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:519522020030404"